NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (5333 d 11:26 ago) – Posting: # 5468
Views: 8,783

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.


If you investigate steady state PK you can do an "active washout" without interrupting treatment.

Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,362 posts in 4,906 threads, 1,674 registered users;
27 visitors (0 registered, 27 guests [including 11 identified bots]).
Forum time: 00:50 CET (Europe/Vienna)

You are rewarding a teacher poorly
if you remain always a pupil.    Friedrich Nietzsche

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5